These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8117411)

  • 1. Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease.
    Kuiper MA; van Kamp GJ; Bergmans PL; Scheltens P; Wolters EC
    J Neural Transm Park Dis Dement Sect; 1993; 6(2):145-9. PubMed ID: 8117411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.
    Pirttila T; Mehta PD; Frey H; Wisniewski HM
    Neurobiol Aging; 1994; 15(3):313-7. PubMed ID: 7936055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.
    Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K
    Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum alpha 1-antichymotrypsin level as a marker for Alzheimer-type dementia.
    Lieberman J; Schleissner L; Tachiki KH; Kling AS
    Neurobiol Aging; 1995; 16(5):747-53. PubMed ID: 8532107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease.
    Hinds TR; Kukull WA; Van Belle G; Schellenberg GD; Villacres EC; Larson EB
    Neurobiol Aging; 1994; 15(1):21-7. PubMed ID: 8159260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type.
    Matsubara E; Amari M; Shoji M; Harigaya Y; Yamaguchi H; Okamoto K; Hirai S
    Prog Clin Biol Res; 1989; 317():707-14. PubMed ID: 2690117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum alpha 1-antichymotrypsin in senile dementia].
    Nagao T; Hamamoto M; Hagiwara M; Kanda A; Ichiseki H; Miyazaki T; Isse K; Tanaka K; Ogura M; Tsushima T
    Nihon Ronen Igakkai Zasshi; 1992 Oct; 29(10):778-82. PubMed ID: 1460783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological alpha 1-antichymotrypsin in patients with probable senile dementia of Alzheimer type: a short-term longitudinal study.
    Licastro F; Davis LJ; Polazzi E; Rossi S; Cucinotta D
    Alzheimer Dis Assoc Disord; 1996; 10(4):192-6. PubMed ID: 8939278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased chemiluminescence response of neutrophils from the peripheral blood of patients with senile dementia of the Alzheimer's type.
    Licastro F; Morini MC; Davis LJ; Malpassi P; Cucinotta D; Parente R; Melotti C; Savorani G
    J Neuroimmunol; 1994 Apr; 51(1):21-6. PubMed ID: 8157733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological alpha 1-antichymotrypsin in Down's syndrome and Alzheimer's disease.
    Brugge K; Katzman R; Hill LR; Hansen LA; Saitoh T
    Ann Neurol; 1992 Aug; 32(2):193-7. PubMed ID: 1387300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.
    Porcellini E; Davis EJ; Chiappelli M; Ianni E; Di Stefano G; Forti P; Ravaglia G; Licastro F
    Curr Pharm Des; 2008; 14(26):2659-64. PubMed ID: 18991685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.
    Licastro F; Masliah E; Pedrini S; Thal LJ
    Dement Geriatr Cogn Disord; 2000; 11(1):25-8. PubMed ID: 10629358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response.
    Licastro F; Morini MC; Polazzi E; Davis LJ
    J Neuroimmunol; 1995 Mar; 57(1-2):71-5. PubMed ID: 7535791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients.
    Altstiel LD; Lawlor B; Mohs R; Schmeidler J; Dalton A; Mehta P; Davis K
    Dementia; 1995; 6(1):17-20. PubMed ID: 7728215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset Alzheimer's disease.
    Licastro F; Sirri V; Trerè D; Davis LJ
    Dement Geriatr Cogn Disord; 1997; 8(6):337-42. PubMed ID: 9370085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte thiolmethyltransferase: another failed marker for Alzheimer's and Parkinson's diseases.
    Hurwitz A; Hubble JP; Glatt SL; Koller WC; Pollack J
    Neurology; 1995 Oct; 45(10):1903-6. PubMed ID: 7477990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
    de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
    Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of serum markers related to several mechanisms in Alzheimer's disease.
    Teunissen CE; Lütjohann D; von Bergmann K; Verhey F; Vreeling F; Wauters A; Bosmans E; Bosma H; van Boxtel MP; Maes M; Delanghe J; Blom HJ; Verbeek MM; Rieckmann P; De Bruijn C; Steinbusch HW; de Vente J
    Neurobiol Aging; 2003 Nov; 24(7):893-902. PubMed ID: 12928047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.